GHUCCTS

News

Share This
  • May 01, 2020

NIH awards $24M to GHUCCTS to support clinical and translational research

WASHINGTON (May 1, 2020) - The Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS) has received a $24.3 million Clinical and Translational Science Award from the National Center for Advancing Translational Science, a part of the National Institutes of Health.

The competitive renewal represents the third 5-year award for the center, which has secured $89.8 million in research funding over 15-years for its member institutions: Georgetown University, Howard University, MedStar Health Research Institute, the Washington DC Veterans Affairs Medical Center and Oak Ridge National Laboratory.

Led by principal investigators Joseph Verbalis, MD, from Georgetown University and Thomas Mellman, MD, from Howard University, the mission of GHUCCTS is to advance research and training with excellence, innovation, collaboration, and efficiency while realizing the potential of the unique capacities of its constituent institutions for developing new technologies, promoting ethical clinical and translational research, and engaging the diverse populations of our communities that have been historically underrepresented in clinical research, including people from diverse racial, ethnic, and cultural backgrounds, people with disabilities, and older adults.

“One of the major missions of GHUCCTS has been to stimulate and support the growth of team science,” says Verbalis, a professor of medicine at Georgetown. “Advances in solving the complex and challenging health problems we face today can be achieved more quickly and efficiently by collaborations among investigators from different scientific disciplines working together on common problems.”

“GHUCCTS was built on a unique model of co-leadership between Georgetown and Howard University, a Historically Black University,” says Mellman, a professor of psychiatry at Howard. “The partnership has influenced prioritizing health disparities and diversity in our training and research missions. Diversity of institutional cultures and of the disciplines represented in our programs has been a founding and enduring strength of GHUCCTS.” 

As one of 60 national CTSA programs, GHUCCTS has transformed research in the greater Washington DC region. Verbalis and Mellman along with faculty members from all of the GHUCCTS institutions and numerous collaborators across the region have achieved impressive goals over the last 10 years, including:

With this new award, GHUCCTS will continue to develop and promote innovative clinical and translational science research to improve the health of the greater Washington DC population.

Download PDF

Related News

GHUCCTS announces 2022 KL2 Scholar Dr. Amanda Blair Spence

Nov 07, 2022

The Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS) is pleased to announce the appointment of Amanda Blair Spence, MD as the 2nd KL2 Scholar selected in our highly-competitive 2022 cycle. This new awardee, her research projects, and training plan are emblematic of our program objectives in that they pair a highly-promising junior faculty scholar-trainee with a mentor team that includes senior colleagues from across disciplines, departments, campuses, and institutions to pursue research that depends upon collaborations and methods from outside the scholars’ discipline, local research environment, or past experiences.

2022 DC CTSA Conference Recordings

Nov 01, 2022

Session recordings are now available from the DC CTSA Consortium's 2022 DC CTSA Spring Regulatory Update & Hot Topics in Clinical and Translational Research.

2022 REKS Summer Series Recording: Regulatory and Ethics in Innovative Community Research

Oct 25, 2022

Recordings for the 2022 REKS Summer Series are now available. The goal of these series is to highlight and discuss innovative community research, regulatory requirements, and ethical implications.

Close